Patrys (ASX:PAB) Share Price and News

Market Cap (22-May) $4,114,900 (1,059th)	Close (30-Jun) $0.010 0 (0%)	Volume (30-Jun) 1,641,703	Shortsold (24-Jan) 39,007 (0.00%) (630th)
52w High $0.008	52w Low $0.002	P/E -	EPS 0

	Subject
	PAB PAB Ann: PAT-DX1 GLP toxicology reports received
	1 (current) 2 3
	PAB PAB Ann: Notification regarding unquoted securities - PAB
	PAB PAB Ann: Appendix 4C - Quarterly - 31 March 2023
	PAB PAB Ann: Notification of cessation of securities - PAB
	PAB PAB Ann: Two new deoxymab patents granted in the USA
	PAB PAB Ann: Updated guidance for PAT-DX1 phase 1 clinical study
	PAB PAB Ann: New PAT-DX3 data demonstrates synthetic lethality
	PAB PAB Ann: Appendix 4D - Half Year Accounts - 31 December 2022
	PAB PAB Ann: Application for quotation of securities - PAB
	PAB PAB Ann: Change in substantial holding
	PAB PAB Ann: Change in substantial holding
	PAB PAB Ann: Change in substantial holding
	PAB PAB Ann: Appendix 4C - Quarterly - 31 December 2022
	PAB PAB Ann: Patrys Receives R&D Tax Incentive Refund
	PAB PAB Ann: Response to ASX Price Query
	PAB PAB Ann: Investor Webinar Presentation
	PAB PAB Ann: Final Director's Interest Notice
	PAB PAB Ann: Initial Director's Interest Notice
	PAB PAB Ann: Notification regarding unquoted securities - PAB
	PAB PAB Ann: Results of Annual General Meeting
	PAB PAB Ann: Chairman's Address and CEO Presentation to 2022 AGM
	PAB PAB Ann: Patrys Appoints Dr Charmaine Gittleson as Chairman
	PAB PAB Ann: Appendix 4C - Quarterly - 30 September 2022
	PAB PAB Ann: PAT DX3 Crosses Blood Brain Barrier in Healthy Animals
	PAB PAB Ann: Notification of cessation of securities - PAB
	PAB PAB Ann: Notice of Annual General Meeting/Proxy Form
	PAB PAB Ann: Final Director's Interest Notice
	PAB PAB Ann: Investor presentation
	PAB PAB Ann: Initial Director's Interest Notice
	PAB PAB Ann: Appointment of Non-Executive Director
	PAB PAB Ann: Appendix 4G and Corporate Governance Statement
	PAB PAB Ann: Appendix 4E and 2022 Annual Report
	PAB PAB Ann: PAT-DX1 From Engineering Run Meets all Specification Tests
	PAB PAB Ann: New Research Grant For Deoxymabs in Metastatic Breast Cancer
	PAB PAB Ann: PAT-DX1/Radiation Combination Improves Brain Cancer Survival
	PAB PAB Ann: Retirement of Non-Executive Chair
	PAB PAB Ann: Appendix 4C - Quarterly - 30 June 2022
	PAB PAB Ann: Change in substantial holding
	PAB PAB Ann: PAT-DX1 Engineering Run Successfully Completed
	PAB PAB Ann: New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis
	PAB PAB Ann: CBCF funding to support deoxymab brain cancer development
	PAB PAB Ann: Patrys CEO to present at Bioshares Biotech Summit
	PAB PAB Ann: Appendix 4C - Quarterly - 31 March 2022
	PAB PAB Ann: Patrys strengthens executive team on path to clinic
	PAB PAB Ann: Section 708A Cleansing Statement
	PAB PAB Ann: Application for quotation of securities - PAB
	PAB PAB Ann: Stable Cell Line for Production of PAT-DX3 Established
	PAB PAB Ann: Appendix 4D - Half Year Accounts - 31 December 2021
	PAB PAB Ann: Application for quotation of securities - PAB
	PAB PAB Ann: Appendix 4C - Quarterly - 31 December 2021

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
21-May	$0.00	642,278	0.00 (0.00%)
19-May	$0.00	7,034,002	0.00 (0.00%)
16-May	$0.00	37,000	0.00 (0.00%)
15-May	$0.00	308,334	0.00 (0.00%)
14-May	$0.00	1,590,000	0.00 (0.00%)
12-May	$0.00	2,354,606	0.00 (33.33%)
08-May	$0.00	354,606	0.00 (0.00%)
07-May	$0.00	0	0.00 (0.00%)
05-May	$0.00	0	0.00 (0.00%)
02-May	$0.00	1,259,055	+0.00 (20.00%)
01-May	$0.00	320,000	+0.00 (25.00%)
30-Apr	$0.00	3,096,000	0.00 (33.33%)
28-Apr	$0.00	0	0.00 (0.00%)
24-Apr	$0.00	0	0.00 (0.00%)
17-Apr	$0.00	169,623	0.00 (0.00%)
2 up, 2 down, and 11 flat days

High $0.01	Low $0.01	Trades 20	Turnover $16,459	Volume 1,641,703
30 June 2023 at 4:10pm

High $0.01	Low $0.01	Trades 20	Turnover $16,459	Volume 1,641,703
30 June 2023 at 4:10pm

Patrys Health Care

$0.010 (0%)

$0.010 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices